HER2 mutation inhibitors
The present invention relates to compounds of formula (I): # imgabs0 # and enantiomers thereof wherein A, L2, R1, R2, R3, R4 and n are as defined herein, as well as pharmaceutically acceptable salts of the formula (I) and the enantiomers. The invention further relates to pharmaceutical compositions...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
26.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!